CLINICAL_TRIALS
trial_result
· 2015-12-15
Clinical Trial Update: Study on Lixisenatide and Counterregulation to Hypoglycemia [Phase 4]
Summary
A Phase 4 clinical trial evaluating lixisenatide and counterregulation to hypoglycemia in type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lund University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED